Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck KGaA Says FDA Extends Review of MS Pill in Setback Against Novartis
Merck KGaA Says FDA Extends Review of MS Pill in Setback Against Novartis
Merck KGaA Says FDA Extends Review of MS Pill in Setback Against Novartis
Submitted by
admin
on November 27, 2010 - 1:15pm
Source:
Bloomberg
News Tags:
Merck KGaA
FDA
MS
multiple sclerosis
Novartis
Darmstadt
Headline:
Merck KGaA Says FDA Extends Review of MS Pill in Setback Against Novartis
Do Not Allow Advertisers to Use My Personal information
